Status:
UNKNOWN
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Lead Sponsor:
Alberta Health services
Conditions:
Liver Tumors
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients with primary hepato-biliary malignancies or liver metastases from gastrointestinal cancer suffer substantial morbidity and mortality from their hepatic disease. Curative resection is feasible...
Eligibility Criteria
Inclusion
- Histologically conformation of liver malignancy
- Solitary or multiple liver tumors amenable to SBRT
- No jaundice or liver dysfunction
- For metastases, the primary tumor site has been adequately treated.
- For primary hepatoma, no extra-hepatic disease
- Karnofsky \> 70
Exclusion
- no extra-hepatic disease
- Liver failure or inadequate liver function
- Ascites
- Previous radiation therapy to the liver
- lesions invading major blood vessels in the porta region
- Contraindication to receive radiation therapy in the liver
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00691691
Start Date
November 1 2007
Last Update
January 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2